$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Vitronectin receptor antagonist pharmaceuticals

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-051/00
  • A61M-036/14
  • A61M-036/00
출원번호 US-0281015 (2002-10-26)
발명자 / 주소
  • Harris,Thomas D.
  • Barrett,John A.
  • Carpenter, Jr.,Alan P.
  • Rajopadhye,Milind
출원인 / 주소
  • Bristol Myers Squibb Pharma Company
대리인 / 주소
    Woodcock Washburn LLP
인용정보 피인용 횟수 : 0  인용 특허 : 49

초록

The present invention describes novel compounds of the formula: description="In-line Formulae" end="lead"(Q) d--Ln--Ch,description="In-line Formulae" end="tail" useful for the diagnosis and treatment of cancer, methods of imaging tumors in a patient, and methods of treating cancer in a patient. Th

대표청구항

What is claimed is described below: 1. An MRI contrast agent, comprising: a metal, wherein , the metal is a paramagnetic metal ion selected from the group: Gd(III), Dy(III), Fe(III), and Mn(II), a chelator capable of chelating the metal, and a targeting moiety, wherein the targeting moiety is bound

이 특허에 인용된 특허 (49)

  1. Keana John F. W. (Eugene OR), Amplifier molecules derived from diethylene triaminepentaacetic acid for enhancement of diagnosis and therapy.
  2. Sakamoto, Izumi; Takagi, Kunihiko, Anti-cancer device.
  3. Bevilacqua Michael P. (La Jolla CA) Gimbrone Michael A. (Jamaica Plain MA), Antibodies specific for ELAM-1 and the use thereof.
  4. Thorpe Philip E. (Dallas TX) Burrows Francis J. (San Diego CA), Antibodies that bind to endoglin.
  5. Nosco Dennis L. (Florissant MO) Nema Sandeep (St. Louis MO) Klibanov Alexander L. (St. Louis MO) Adzamli Kofi (Chesterfield MO), Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging.
  6. Kuntz Emile (Lyons FRX), Catalytic hydroformylation of olefins.
  7. Bridger Gary J. (Bryn Mawr PA) Hernandez Pedro E. (Malvern PA) Higgins ; III John D. (West Chester PA) Larsen Scott K. (West Chester PA), Complexes with 99mTc suitable for radiolabelling monoclonal antibodies or other macro molecules.
  8. Thorpe Philip E. ; Burrows Francis J., Compositions for targeting the vasculature of solid tumors.
  9. Thorpe Philip E. ; Burrows Francis J., Compositions for targeting the vasculature of solid tumors.
  10. Klaveness Jo,NOX ; Naevestad Anne,NOX ; Cuthbertson Alan,NOX ; Solbakken Magne,NOX, Contrast agents.
  11. Klaveness, Jo; Naevestad, Anne; Tolleshaug, Helge, Contrast agents.
  12. Long Jeffrey R. ; Xheng Xhiping ; Holm Richard H. ; Yu Shi-Bao ; Droege Michael ; Sanderson William A., Contrast agents.
  13. Keana John F. W. (Eugene OR) Martin Vladimir (Eugene OR) Ralston William H. (St. Charles MO), Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group.
  14. Bergstein Paul L. (Norwood MA) Subramanyam Vinayakam (Wilmington DE), Ether isonitriles and radiolabeled complexes thereof.
  15. Wallace Rebecca A. (Manchester MO), Functionalized aza-crytand ligands for diagnostic imaging applications.
  16. Cacheris William P. (San Jose CA) Quay Stephen C. (Sunnyvale CA), Heterocyclic derivatives of DTPA used for magnetic resonance imaging.
  17. Pollak Alfred (Toronto CAX) Kirby Robert A. (Acton CAX) Dunn-Dufault Robert (Bramalea CAX), Hydrazino-type radionuclide chelators having an N3S configuration.
  18. Morgan ; Jr. A. Charles (Edmonds WA), Imaging tissue sites of inflammation.
  19. Duggan Mark E. ; Hartman George D., Integrin receptor antagonists.
  20. Love David B. (Wayne PA) Dow William C. (Wayne PA) Himmelsbach Richard J. (Wayne PA) Watson Alan D. (Wayne PA) Rocklage Scott M. (Wayne PA), Linear oligomeric polychelant compounds.
  21. Selvin Paul R. (Berkeley CA) Hearst John (Berkeley CA), Luminescent lanthanide chelates and methods of use.
  22. Snow Robert A. ; Delecki Daniel J. ; Shah Chandra R., Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods.
  23. Gansow Otto A. (3003 Van Ness ; NW. ; W 524 Washington DC 20008) Strand Mette (807 Harper House ; Village of Cross Keys Baltimore MD 21210), Metal chelate conjugated monoclonal antibodies.
  24. Tweedle Michael F. ; Gaughan Glen T.,GBX ; Hagan James J., Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs.
  25. Kronhamn Thomas Rolf,SEX, Method for position determination.
  26. Gries Heinz (Berlin DEX) Rosenberg Douwe (Berlin DEX) Weinmann Hanns-Joachim (Berlin DEX) Speck Ulrich (Berlin DEX) Mtzel Wolfgang (Berlin DEX) Hoyer Georg-Alexander (Berlin DEX) Pfeiffer ; deceased , Method of enhancing NMR imaging using chelated paramagnetic ions bound to biomolecules.
  27. Brooks Peter ; Cheresh David A., Methods and compositions useful for inhibition of angiogenesis.
  28. Thorpe Philip E. ; Burrows Francis J., Methods for targeting the vasculature of solid tumors.
  29. Thorpe Philip E. ; Burrows Francis J., Methods for treating the vasculature of solid tumors.
  30. Waldman Scott A., Methods of treating metastatic colorectal cancer with ST receptor binding compounds.
  31. Garin-Chesa Pilar (New York NY) Rettig Wolfgang J. (New York NY) Old Lloyd J. (New York NY), Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium,.
  32. Albert Rainer (Basel CHX) Macke Helmut (Lorrach DEX), Peptides.
  33. Love David B. (Campbell CA) Dow William C. (Fremont CA) Himmelsbach Richard J. (Pleasanton CA) Watson Alan D. (Campbell CA) Rocklage Scott M. (Los Gatos CA), Polychelant compounds.
  34. Ranney David F. (Dallas TX), Polychelating agents for image and spectral enhancement (and spectral shift).
  35. Hollister Kenneth Robert ; Keller Kenneth Edmund ; Wei Dong ; Peng Xin ; Ladd David Lee ; Henrichs Paul Mark ; Snow Robert Allen, Polymeric contrast agents for medical imaging.
  36. Glajch Joseph L ; Carpenter ; Jr. Alan P. ; Cheesman Edward H., Porous inorganic targeted ultrasound contrast agents.
  37. Kruper ; Jr. William J. (Sanford MI), Process for preparing mono-n-alkylated polyazamacrocycles.
  38. Lyle Leon R. (Webster Groves MO) Rajagopalan Raghavan (Maryland Heights MO) Deutsch Karen (Maryland Heights MO), Radiolabelled peptide compounds.
  39. Stuttle Alan W. J. (London GBX), Synthetic peptides for use in tumor detection.
  40. Flanagan Richard J. (St. Lazare CAX) Dufour Jean-Marc (Pierrefonds CAX) Hogan Keith T. (Dorval CAX), TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications.
  41. Klaveness Jo,NOX ; Rongved P.ang.l,NOX ; L.o slashed.vhaug Dagfinn,NOX, Targeted ultrasound contrast agents.
  42. Edwards David Scott ; Liu Shuang, Ternary radiopharmaceutical complexes.
  43. Toner John L. (Webster NY), Terpyridine chelating agents.
  44. Allen Theresa M.,CAX ; Uster Paul ; Martin Francis J. ; Zalipsky Samuel, Therapeutic liposome composition and method of preparation.
  45. Senger Donald R. (Medfield MA) Dvorak Harold F. (Newton MA), Vascular permeability factor targeted compounds.
  46. Cheesman, Edward H.; Barrett, John A.; Carpenter, Jr., Alan P.; Rajopadhye, Milind; Sworin, Michael, Vitronectin receptor antagonist pharmaceuticals.
  47. Harris, Thomas D.; Barrett, John A.; Carpenter, Jr., Alan P.; Rajopadhye, Milind, Vitronectin receptor antagonist pharmaceuticals.
  48. Harris, Thomas D.; Rajopadhye, Milind, Vitronectin receptor antagonist pharmaceuticals.
  49. Harris, Thomas D.; Rajopadhye, Milind, Vitronectin receptor antagonist pharmaceuticals.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트